Bombay Super Hybrid Seeds Ltd
₹ 136
-3.32%
25 Apr
- close price
- Market Cap ₹ 1,430 Cr.
- Current Price ₹ 136
- High / Low ₹ 226 / 116
- Stock P/E 56.5
- Book Value ₹ 8.71
- Dividend Yield 0.00 %
- ROCE 23.9 %
- ROE 33.0 %
- Face Value ₹ 1.00
Pros
- Company has reduced debt.
- Company is expected to give good quarter
- Company has delivered good profit growth of 61.5% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 33.1%
Cons
- Stock is trading at 15.6 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Tax rate seems low
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: FMCG Industry: Miscellaneous
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|
31 | 63 | 110 | 82 | 75 | 103 | 171 | 191 | 228 | 256 | 343 | |
30 | 62 | 108 | 79 | 70 | 97 | 162 | 178 | 206 | 228 | 313 | |
Operating Profit | 1 | 1 | 1 | 3 | 4 | 6 | 9 | 14 | 22 | 28 | 30 |
OPM % | 3% | 2% | 1% | 4% | 6% | 6% | 5% | 7% | 9% | 11% | 9% |
0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 3 | |
Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 5 | 6 |
Depreciation | 0 | 0 | 0 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 |
Profit before tax | 0 | 0 | 1 | 2 | 3 | 3 | 6 | 11 | 18 | 24 | 26 |
Tax % | 62% | 37% | 34% | 35% | 26% | 23% | 5% | 5% | 6% | 6% | |
0 | 0 | 1 | 1 | 2 | 3 | 6 | 10 | 17 | 22 | 25 | |
EPS in Rs | 0.01 | 0.05 | 0.16 | 0.15 | 0.20 | 0.25 | 0.55 | 1.00 | 1.60 | 2.12 | 2.42 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 28% |
3 Years: | 15% |
TTM: | 31% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 62% |
3 Years: | 57% |
TTM: | 21% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 75% |
3 Years: | 45% |
1 Year: | -37% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 29% |
3 Years: | 33% |
Last Year: | 33% |
Balance Sheet
Figures in Rs. Crores
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 2 | 3 | 3 | 5 | 7 | 8 | 10 | 10 | 10 | 10 | 10 |
Reserves | 0 | 0 | 1 | 3 | 14 | 15 | 18 | 29 | 46 | 68 | 81 |
6 | 7 | 12 | 16 | 13 | 16 | 30 | 39 | 53 | 48 | 37 | |
1 | 4 | 4 | 7 | 4 | 8 | 13 | 19 | 24 | 36 | 33 | |
Total Liabilities | 8 | 15 | 20 | 31 | 38 | 47 | 73 | 98 | 133 | 162 | 162 |
2 | 3 | 5 | 4 | 9 | 9 | 8 | 7 | 9 | 7 | 9 | |
CWIP | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
7 | 12 | 15 | 24 | 29 | 38 | 64 | 91 | 124 | 155 | 153 | |
Total Assets | 8 | 15 | 20 | 31 | 38 | 47 | 73 | 98 | 133 | 162 | 162 |
Cash Flows
Figures in Rs. Crores
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|
1 | -2 | -5 | -0 | -8 | -12 | -8 | 12 | |||
-3 | -2 | -3 | -1 | -1 | -0 | -3 | -2 | |||
2 | 5 | 7 | 1 | 14 | 7 | 10 | -9 | |||
Net Cash Flow | -0 | 2 | -2 | 0 | 5 | -5 | -0 | 0 |
Ratios
Figures in Rs. Crores
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 17 | 15 | 12 | 19 | 15 | 25 | 16 | 31 | 14 | 14 |
Inventory Days | 55 | 50 | 30 | 71 | 143 | 121 | 169 | 281 | 497 | 406 |
Days Payable | 3 | 12 | 8 | 13 | 5 | 6 | 7 | 30 | 51 | 27 |
Cash Conversion Cycle | 70 | 52 | 34 | 76 | 152 | 140 | 179 | 282 | 460 | 393 |
Working Capital Days | 67 | 41 | 34 | 67 | 118 | 106 | 100 | 139 | 161 | 169 |
ROCE % | 10% | 15% | 14% | 13% | 13% | 15% | 19% | 22% | 24% |
Documents
Announcements
-
Credit Rating- Others
16 April 2025 - CARE assigns BBB; Stable and A3+ ratings to bank facilities
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
15 April 2025 - Submission of SEBI Reg 74(5) certificate for quarter ended March 31, 2025
-
Credit Rating- New
2 April 2025 - CARE assigns BBB Stable/A3+ on Rs125 Cr bank facilities
-
Trading Window-XBRL
26 March 2025 - Bombay Super Hybrid Seeds Limited has informed about Closure of Trading Window
-
Trading Window
26 March 2025 - Trading window closed from April 1, 2025 until 48 hours after audited Q4 FY25 financial results
Product Portfolio
The company is engaged in the production, processing, and marketing of hybrid and GM seeds. It offers a range of over 150 products, including field crops and vegetable crops such as groundnut, chickpea, coriander, sesame, and maize. [1] [2] [3] [4]